Registry-based assessment of the status of cervical screening in Sweden

Journal of Medical Screening

Volumn 23, Issue 4, 2016, Pages 217-226

  Elfström, K Miriam ^a   Sparén, Pär ^a   Olausson, Peter ^a   Almstedt, Pouran ^a   Strander, Björn ^b,c   Dillner, Joakim ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Regional Cancer Center   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical cancer; Prevention; Quality indicators; Registry; Screening

Indexed keywords

ADULT; FEMALE; HUMAN; INCIDENCE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PATHOLOGY; PROCEDURES; REGISTER; STATISTICS AND NUMERICAL DATA; SWEDEN; UTERINE CERVIX TUMOR; UTILIZATION; YOUNG ADULT;

ADULT; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAPANICOLAOU TEST; REGISTRIES; SWEDEN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 85020036170     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316632023     Document Type: Article

References (14)

1. Coleman D, Day N, Douglas G, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 1993; 29A: S1-38.
2. Arbyn M, Anttila A, Jordan J, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 2008.
3. von Karsa L, Arbyn M, De Vuyst H, et al. European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Res 2015; 1: 22-31.
4. Anttila A, von Karsa L, Aasmaa A, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009; 45: 2649-2658.
5. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100: 622-629.
6. Statens Offentliga Utredningar. En nationell cancerstrategi fo¨r framtiden. Stockholm: The Swedish Government, 2009.
7. Elfstrom KM, Arnheim-Dahlstrom L, von Karsa L, et al. Cervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer 2015; 51: 950-968.
8. Ronco G, Giubilato P, Naldoni C, et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity. Epidemiol Prev 2010; 34: 35-51.
9. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 1985; 92: 150-157.
10. Blanks RG, Waller M, Sanchez-Galvez A, et al. Monitoring and evaluating the performance of the UK NHS Cervical Screening Programme: monitoring performance by using cytology outcomes adjusted for population characteristics. Cytopathology 2004; 15: 5-11.
11. Castanon A, Ferryman S, Patnick J, et al. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers. Cytopathology 2012; 23: 13-22.
12. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003; 89: 88-93.
13. Vooijs GP, Casparie-van Velsen IA, Peters FA, et al. National registry of cervical cytologic diagnoses in The Netherlands. Acta Cytol 1989; 33: 825-830.
14. Anttila A, Pukkala E, Soderman B, et al. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 1999; 83: 59-65